Connection

Igor Roninson to Trastuzumab

Back to Details
This is a "connection" page, showing publications Igor Roninson has written about Trastuzumab.
Igor Roninson
Connection Strength
0.051
Trastuzumab
  1. Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in?vitro and in?vivo. Proc Natl Acad Sci U S A. 2022 08 09; 119(32):e2201073119.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.